We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
Price Change | % Change | Price | |
---|---|---|---|
-0.23 | -0.22% | 104.52 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
106.775 | 104.47 | 106.18 | 3,665,338 | 01:00:00 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
31 Jan 2025 | 104.72 | -0.03 | -0.03% | 104.47 | 106.775 | 3,620,683 |
30 Jan 2025 | 104.75 | 1.82 | 1.77% | 103.15 | 105.04 | 2,700,926 |
29 Jan 2025 | 102.93 | 1.09 | 1.07% | 102.675 | 103.27 | 2,375,313 |
28 Jan 2025 | 101.84 | -1.57 | -1.52% | 101.755 | 102.91 | 2,011,912 |
27 Jan 2025 | 103.41 | 3.44 | 3.44% | 102.02 | 103.49 | 2,289,897 |
24 Jan 2025 | 99.97 | 1.80 | 1.83% | 99.12 | 99.995 | 1,681,793 |
23 Jan 2025 | 98.17 | 0.00 | 0.00% | 98.17 | 98.17 | 0 |
22 Jan 2025 | 98.17 | -1.56 | -1.56% | 98.12 | 99.24 | 1,498,846 |
21 Jan 2025 | 99.73 | 2.20 | 2.26% | 98.30 | 100.095 | 1,891,651 |
17 Jan 2025 | 97.53 | -0.33 | -0.34% | 97.45 | 98.505 | 1,483,637 |
16 Jan 2025 | 97.86 | -1.21 | -1.22% | 97.39 | 99.7783 | 3,111,719 |
15 Jan 2025 | 99.07 | -0.30 | -0.30% | 98.908 | 99.73 | 1,303,891 |
14 Jan 2025 | 99.37 | 0.10 | 0.10% | 98.20 | 99.44 | 1,797,235 |
13 Jan 2025 | 99.27 | 0.19 | 0.19% | 98.46 | 99.27 | 1,467,207 |
10 Jan 2025 | 99.08 | -1.14 | -1.14% | 99.03 | 99.72 | 1,400,065 |
08 Jan 2025 | 100.22 | 1.24 | 1.25% | 98.53 | 100.67 | 1,818,230 |
07 Jan 2025 | 98.98 | 1.28 | 1.31% | 98.72 | 99.58 | 1,363,539 |
06 Jan 2025 | 97.70 | 0.06 | 0.06% | 97.475 | 98.4582 | 1,376,350 |
03 Jan 2025 | 97.64 | 0.50 | 0.51% | 97.18 | 97.90 | 1,401,989 |
02 Jan 2025 | 97.14 | -0.17 | -0.17% | 96.91 | 98.00 | 1,084,879 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions